Evidence map›Paper›PMID 26446086›Full record

ArticleParasitology research2016

Effect of Nigella sativa oil on experimental toxoplasmosis.

Rasha F Mady, Wessam El-Hadidy, Samar Elachy

Abstract read
PubMed Publisher
In one paragraph

Article in Parasitology research, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
2.1field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 47 citations in OpenAlex.

  1. Anti-Advanced biomedical research · 2026
    Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. The potential therapeutic effect ofJournal of parasitic diseases : official organ of the Indian Society for Parasitology · 2023
    Article
  9. Article
  10. Remarkable histopathological improvement of experimental toxoplasmosis after receiving spiramycin-chitosan nanoparticles formulation.Journal of parasitic diseases : official organ of the Indian Society for Parasitology · 2022
    Article
  11. Review
  12. The protective effect ofToxicology reports · 2022
    Article
  13. Effect ofFrontiers in pharmacology · 2022
    Article
  14. ThymocidNutrients · 2020
    Article
  15. Article
  16. Anti-Bioscience reports · 2019
    Article
  17. Review
  18. Assessment of spiramycin-loaded chitosan nanoparticles treatment on acute and chronic toxoplasmosis in mice.Journal of parasitic diseases : official organ of the Indian Society for Parasitology · 2018
    Article
  19. Protective Effect ofAudiology research · 2017
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Rasha F MadyMedical Parasitology, Faculty of Medicine, Alexandria University, Alexandria, Egypt. rasha.madi@alexmed.edu.eg.
Wessam El-HadidyPharmacology and Experimental Therapeutics Department, Medical Research Institute, Alexandria University, Alexandria, Egypt.
Samar ElachyPathology Department, Faculty of Medicine, Alexandria University, Alexandria, Egypt.
Alexandria University · EG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Toxoplasmosis is a parasitic infection caused by Toxoplasma gondii protozoon. It is most commonly treated by pyrimethamine (PYR); however, this was intolerable by many patients. The aim of this study was to assess therapeutic effects of Nigella sativa oil (NSO) alone and combined with pyrimethamine (PYR) compared to a previous combination of clindamycin (CLN) and (PYR). One hundred Albino mice were used in the current study and were equally divided into five groups: normal (I), infected untreated control (II); infected, treated with NSO-only (III); infected, treated with NSO + PYR (IV); and infected, treated with CLN + PYR (V). The virulent RH Toxoplasma strain was used in infection survival rates estimation, impression smears from liver and spleen, and histopathological and ultrastructural studies were done. Liver malondialdehyde (MDA) level and total antioxidant capacity (TAC) were determined. Interferon-γ and specific IgM were also measured in sera by ELISA. Results showed that NSO alone has no direct anti-Toxoplasma effect, whereas its combination with PYR produced potent effect that is comparable to CLN + PYR. It significantly increased the survival rate and decreased the parasite density and pathological insult in both liver and spleen. Also, significant increase in interferon-γ level denotes stimulation of cellular immunity. NSO + PYR combination markedly improved the antioxidant capacity of Toxoplasma infected mice compared to the infected untreated ones and to CLN/PYR. In conclusion, although NSO, if administered alone, has significant immunostimulant and antioxidant properties, it failed to decrease tachyzoite counts. Combination of NSO and PYR had synergistic effect in treatment of toxoplasmosis.

Indexed as

AnimalsAntioxidantsAntiprotozoal AgentsCarumDrug Therapy, CombinationHumansImmunoglobulin MInterferon-gammaLiverMaleMalondialdehydeMiceNigella sativaParasite LoadPlant OilsPyrimethamineAntioxidantsAntiprotozoal Agentscaraway oilImmunoglobulin MInterferon-gammaMalondialdehydePlant OilsPyrimethamineAntioxidantCombination therapyInterferon-gammaNigella sativa oilToxoplasma gondii

Identifiers

PMID26446086
OpenAlexW1861765897

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.